Why Pain Management Physicians Get Sued: The Epidural Injection, the Opioid Script, and the Catastrophe

By John Mahoney · June 2026 · 8 min read

Pain management is a deceptively dangerous specialty to litigate, because its two main risk channels look nothing alike. One channel is procedural and catastrophic — an epidural or transforaminal steroid injection that ends in spinal-cord injury, paralysis, infection, or death. The other is prescribing and chronic — an opioid regimen that ends in overdose, with liability built around monitoring records that span years. An attorney who screens a pain-medicine intake as if it were any other diagnostic case will misread both: the injection cases hinge on procedural technique and consent for a rare-but-devastating risk, and the opioid cases hinge on a documented monitoring trail measured against an evolving guideline standard. This guide explains where pain-management liability actually lives, the cannot-miss failures behind it, and what separates a strong case from a weak one — for plaintiff and defense med-mal attorneys.

Disclaimer: This article is for informational purposes only and does not constitute legal advice. The patterns below draw on closed-claims and insurer datasets and commonly reported litigation themes that span different eras and definitions; treat them as directional, verify against the controlling jurisdiction, and value any individual case on its own record.

The Frequency-and-Severity Reality

By raw frequency, pain medicine does not generate the claim volume of surgery or obstetrics, but it sits well above the safest specialties because nearly every patient encounter involves either an invasive procedure or a controlled-substance prescription — two of the most litigated acts in medicine. Pain physicians who do high-volume interventional work face a meaningful annual exposure, and the long-term, recurring nature of chronic-pain treatment means a single patient relationship can span years and generate a claim long after the index encounter.

Severity is where pain management stands apart. The specialty carries a heavy catastrophic tail: an interventional spinal injection that injures the spinal cord can produce paraplegia or quadriplegia, and an opioid regimen that is not monitored can end in death. Both of those outcomes anchor the highest-value claims in the field. Because the worst cases are so severe, average indemnity in pain medicine runs higher than the modest-procedure specialties, and the dollars are concentrated in a small number of catastrophic-injury and wrongful-death files. The screening lesson is that two valuation models live inside this one specialty — a procedural-catastrophe model and a prescribing-monitoring model — and you must route every intake to the right one immediately.

The Dominant Allegation Types

Pain-management claims cluster into an interventional-procedure group and a prescribing group, plus a diagnostic thread and a consent thread that run through both:

• Improper performance of an interventional procedure — the catastrophic core of the specialty: epidural and transforaminal steroid injection injuries, including spinal-cord and nerve damage, intravascular injection, and wrong-level injection.
• Negligent opioid prescribing and management — overdose death, excessive dosing, failure to monitor, and failure to taper, commonly framed against the CDC opioid-prescribing guideline as the standard-of-care reference point.
• Procedure-related infection — epidural abscess, meningitis, and discitis following injection or device implantation, where the allegation is failure to recognize and treat the infection promptly.
• Failure to diagnose underlying pathology presenting as pain — tumor, infection, fracture, or cauda equina syndrome treated as benign chronic pain.
• Lack of informed consent / failure to communicate catastrophic risk — central to the injection cases, where the realized harm (paralysis) is rare but devastating and the consent record is heavily scrutinized.
• Device complications — spinal cord stimulator and intrathecal pump infection, dosing or refill error, and catheter-tip granuloma.

The structural point: by count, the prescribing and procedural categories both generate steady volume, but by dollars, the catastrophic injection injuries and the overdose-death claims dominate. Any intake should be triaged first on which channel it sits in — needle or prescription pad — because the merit analysis, the experts, and the damages are entirely different.

The Cannot-Miss Conditions and Failures

The conditions and failures that drive pain-management litigation are:

• Spinal-cord and nerve injury from spinal injection — paraplegia or quadriplegia. This is the highest-severity exposure. The most-scrutinized scenario is a cervical transforaminal injection of particulate steroid, where intravascular injection into a radicular artery can cause catastrophic cord infarction. The recurring failures are use of particulate steroid where non-particulate was indicated, inadequate or absent imaging guidance, and failure to confirm needle position before injecting.
• Wrong-level injection — injecting at the wrong spinal level, a classic procedural error tied to imaging-confirmation and time-out failures.
• Procedure-related infection — epidural abscess, meningitis, or discitis after injection or implant, where the claim turns on sterile technique and, more often, on the delay in recognizing and treating the infection once symptoms appear.
• Opioid overdose death — the highest-value prescribing exposure, where the recurring failures are excessive dosing, failure to check the prescription drug monitoring program (PDMP), absent urine drug screening, failure to recognize diversion or aberrant behavior, and failure to taper a dangerous regimen.
• Missed underlying pathology — tumor, spinal infection, fracture, or cauda equina syndrome treated as ordinary chronic pain when the record contained red-flag findings.
• Spinal cord stimulator and intrathecal pump complications — device infection, programming or refill dosing error, and catheter-tip granuloma producing neurologic injury.

For the procedural side, the single most actionable screening question is the technique-and-guidance question: was imaging guidance used and documented, was needle position confirmed before injection, and — for cervical transforaminal cases — was a particulate steroid used where the safer non-particulate agent was indicated? For the prescribing side, the decisive question is the monitoring trail: does the chart show the PDMP checks, urine screens, dose decisions, and a treatment agreement that the standard of care expects?

The Contributing Factors That Drive Payouts

Across pain-management closed claims, the recurring contributing factors are:

• Technical skill / improper performance of a procedure — the catastrophic driver: needle placement, use of particulate versus non-particulate steroid, intravascular injection, wrong-level injection, and inadequate imaging guidance. When a spinal injection produces a cord or nerve injury, the technique question carries the case.
• Prescribing judgment and monitoring — the costliest prescribing factor: dose selection, PDMP review, urine drug screening, response to aberrant behavior or diversion, and the decision to continue, escalate, or taper. These records are graded against the CDC opioid-prescribing guideline as a reference standard.
• Failure to recognize and treat complications — the delayed diagnosis of post-procedure infection (abscess, meningitis, discitis) or device complication, where the injury is driven less by the index procedure than by the lag in responding to it.
• Informed consent — failure to convey the catastrophic, low-probability risk of an injection, which makes the consent record decisive when a rare but devastating harm is realized.
• Documentation — incomplete records of consent, imaging guidance, the steroid agent and level injected, monitoring (PDMP, urine screens), and the treatment agreement, all of which weaken the defense.

Two of these are pain-medicine-specific levers. The first is the imaging-and-agent record on the procedural side: in a cervical transforaminal injury case, the line between a defensible file and a paid claim is often whether the chart documents fluoroscopic guidance, contrast confirmation, and the choice of a non-particulate steroid. The second is the monitoring trail on the prescribing side: in an overdose-death case, the case frequently turns on whether the record shows the PDMP checks, urine screens, and the treatment agreement — the documented evidence that the regimen was being monitored, not merely refilled. Documentation rarely creates liability here, but it consistently decides whether a claim is paid.

Strong Case vs. Weak Case in Pain Management Malpractice

The same factors grade the file, and the framing is useful to both sides.

What makes a pain-management case strong (plaintiff) / dangerous (defense)

• A catastrophic spinal-cord or nerve injury after a cervical transforaminal injection of a particulate steroid, with thin or absent documentation of imaging guidance, contrast confirmation, and the agent chosen — a clean technique-and-agent failure.
• A wrong-level injection or an injection performed without documented fluoroscopic confirmation of needle position.
• An opioid overdose death where the chart shows no PDMP checks, no urine drug screens, escalating doses, ignored aberrant-behavior or diversion signals, and no treatment agreement — a clean monitoring-failure record.
• A post-procedure epidural abscess or meningitis with documented red-flag symptoms that went unrecognized and untreated, or a consent form that never mentioned the catastrophic risk that was realized.

What makes a pain-management case weak (plaintiff) / defensible (defense)

• An injection performed with documented fluoroscopic guidance, contrast confirmation of needle position, correct level, and a non-particulate steroid where indicated — technique and agent on the record.
• A catastrophic outcome that was a disclosed, known risk with documented informed consent, framing the harm as a rare accepted risk of a properly performed procedure rather than negligence.
• An opioid regimen supported by a robust monitoring trail — regular PDMP checks, urine drug screens, a signed treatment agreement, documented dose justifications, and an appropriate taper — consistent with the guideline standard.
• A record showing patient non-adherence, diversion, doctor-shopping despite monitoring, or concurrent substances that drove the overdose, breaking the causation chain.

Pain management rewards a fast triage. On the procedural side, the case lives or dies on the technique-and-guidance record and the consent for a catastrophic risk. On the prescribing side, it turns on the monitoring trail measured against the CDC guideline and the causation question of what actually drove the overdose. Whichever side you are on, grading the file means matching the right model to the right claim — needle or prescription pad — and pressure-testing the expert who will carry it.

Bottom Line

Pain-management physicians get sued in two very different ways, and conflating them is the most common screening error. The interventional channel produces a catastrophic tail — epidural and transforaminal injection injuries causing paralysis, infection, or death — where the case turns on technique, imaging guidance, the steroid agent, and consent for a rare devastating risk. The prescribing channel produces overdose-death and excessive-dosing claims, where the case turns on a years-long monitoring trail graded against the CDC opioid guideline. The cannot-miss facts are the particulate steroid in a cervical transforaminal injection, the unconfirmed needle position, the unrecognized post-procedure infection, the missed underlying pathology, and the opioid regimen with no PDMP, no urine screens, and no treatment agreement. Whether you are screening these cases for the plaintiff or defending them, triage first to the right model — procedural or prescribing — and grade the file on the technique-and-guidance record, the monitoring trail, and the documented consent, not on the severity of the injury alone.

Questions? Contact us at [email protected] or (856) 979-6525

🔎 Screening a case in a different specialty? Browse all 70 specialty malpractice-risk guides in one place — Why Doctors Get Sued: Malpractice Risk by Specialty →